In 1994, we concluded in a decision analysis that women who used estrogen therapy from age 50 to 75 years would improve their quality of life.1 Almost 10 years later, we have new evidence on the risk and protective factors associated with hormone therapy (HT) from 4 randomized controlled trials and a more sophisticated decision model presented in the ARCHIVES2 that allows for a more complete balancing of the risks and benefits of hormone use. Despite these gains, important uncertainties remain regarding issues that are pivotal to understanding the role of HT, suggesting the critical need for more research, particularly with regard to the impact of HT on quality of life.
Peterson HB, Thacker SB, Corso PS, Marchbanks PA, Koplan JP. Hormone Therapy: Making Decisions in the Face of Uncertainty. Arch Intern Med. 2004;164(21):2308–2312. doi:10.1001/archinte.164.21.2308
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: